Adalimumab 40mg

Adalimumab 40mg

24900.00 INR/Piece

Product Details:

  • Drug Type Injection
  • Ingredients Adalimumab (40mg)
  • Physical Form Liquid
  • Function Other
  • Recommended For ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohns
  • Dosage Your doctor or nurse will give you this medicine. Kindly do not self administer.
  • Dosage Guidelines Your doctor or nurse will give you this medicine. Kindly do not self administer.
  • Click to View more
X

Price And Quantity

  • 24900.00 INR/Piece
  • 1 Piece

Product Specifications

  • Injection
  • 1 Pieces
  • Other
  • Liquid
  • Store below 30C
  • Your doctor or nurse will give you this medicine. Kindly do not self administer.
  • Your doctor or nurse will give you this medicine. Kindly do not self administer.
  • ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohns
  • Adalimumab (40mg)

Trade Information

  • Telegraphic Transfer (T/T)
  • 10 Piece Per Day
  • 10 Days
  • Within a certain price range free samples are available
  • Australia North America South America Eastern Europe Western Europe Middle East Africa Central America Asia

Product Description

Adaly Injection is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohns disease. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.

Product details 

Country of Origin

Made in India

Strength / Dose

40 mg / 0.8 ml

Packaging Type

Pre Filled Syringe

Manufacturer

Zydus

Brand

Exemptia

Composition

Adalimumab 40mg/0.8ml

Treatment

Ankylosing spondylitis, Rheumatoid arthritis, Psoriasis, Ulcerative colitis, and Crohn's disease

Packaging Size

1 PFS

Form

Injection

 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Pharmaceutical Injection' category



Back to top
trade india member
NIBA HEALTHCARE All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.